Inventor · disambiguated record
Felipe Bedoya
Also filed as: BEDOYA FELIPE
7 granted patents·10 pending applications·50 citations·filing 2006–2025
82Inventor score
Files withNOVARTIS AG8KITE PHARMA INC2MASSACHUSETTS GEN HOSPITAL2TMUNITY THERAPEUTICS INC2UNIV PENNSYLVANIA2
Top patents by PatentIndex Score
17 records- 0194US10829735B2Methods for improving the efficacy and expansion of immune cellsUNIV PENNSYLVANIA·Filed 2016·Granted Nov 10, 2020·14 cites·28 claims
- 0294US10273300B2Methods of making chimeric antigen receptor-expressing cellsUNIV PENNSYLVANIA·Filed 2015·Granted Apr 30, 2019·26 cites·28 claims
- 0391US12240884B2Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2020·Granted Mar 4, 2025·2 cites·24 claims
- 0491US10774388B2Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2015·Granted Sep 15, 2020·7 cites·31 claims
- 0575US2023295296A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0672US2024398913A1Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0770US2023322923A1Methods and compositions relating to ex vivo culture and modulation of t cellsMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 0869US2025230217A1Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0965US2024228959A9Large scale car-t immune cell manufacturing method utilizing lentiviral vector transfectionKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1064US11613574B2Methods and compositions relating to ex vivo culture and modulation of T cellsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Mar 28, 2023·0 cites·17 claims
- 1162US2021172020A1Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1257US9163071B2POP2: NKκB-inhibiting polypeptides, nucleic acids and methods of useHARTON JONATHAN A·Filed 2006·Granted Oct 20, 2015·1 cites·1 claims
- 1356US2019292257A1Methods of making chimeric antigen receptor - expressing cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1455US2025090579A1Dnvsig3 and dnvsig8 receptors and methods of using the sameKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 1555US2023190809A1Alternative generation of allogeneic human t cellsTMUNITY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1654US11896614B2Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2016·Granted Feb 13, 2024·0 cites·15 claims
- 1752US2024060089A1Vector-free process for manufacture of engineered immune cellsTMUNITY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Felipe Bedoya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →